News
Conduct CT in India: CDSCO Panel tells Novo Nordisk India For new formulation of Semaglutide tablets
The committee noted that semaglutide tablets 3 mg, 7 mg, and 14 mg are approved for marketing in India. The firm has claimed ...
11h
Verywell Health on MSNMedication Options for Managing Kidney DiseaseExplore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...
Scholar Rock Holding Corporation's apitegromab shows promise for SMA treatment, aims for 2025 launch. Click for my updated ...
Leveraging AI, researchers have identified a naturally occurring molecule that can suppress appetite and facilitate weight loss in mice and pigs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results